** UnitedHealth Group UNH.N reported an "unusual and unacceptable" quarterly earnings miss, leading to a lowered full-year outlook due to higher-than-expected medical costs
** Median PT of 29 brokerages covering the stock is $609 - LSEG data
TREATING MARKET SYMPTOMS
** J.P.Morgan ("overweight") believes co is proactively addressing ongoing challenges, and expects these difficulties to persist throughout the year
** Mizuho ("outperform," PT: $650) sees co's initial medical loss ratio guidance as overly optimistic, not fully accounting for rapid growth and generous plan benefits
** Oppenheimer ("outperform," PT: $600) believes co's company-specific issues, particularly affecting its OptumHealth business due to market exits by major competitors, creating short-term uncertainty until Q2 cost trends are clarified
** Piper Sandler ("overweight," PT: $592) believes co's stability and integrated care delivery assets will support recovery and durable earnings growth by CY26
(Reporting by Rashika Singh in Bengaluru)
((rashika.singh@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。